Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF

Appili Therapeutics Inc Class A (APLIF) Financial Statements

81 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently ―. The company's EPS TTM is $-0.023; its P/E ratio is -1.08; Appili Therapeutics Inc Class A is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total RevenueC$ 11.70KC$ 478.40KC$ 337.31K-C$ 334.18K
Gross ProfitC$ 11.70KC$ 478.40KC$ 337.31K-C$ 334.18K
EBITC$ -711.59KC$ 292.38KC$ -506.34KC$ -1.15MC$ -2.16M
EBITDAC$ -708.20KC$ 292.38KC$ -502.90KC$ -1.15MC$ -2.16M
Net Income Common StockholdersC$ -1.10MC$ -152.34KC$ -976.55KC$ -1.55MC$ -2.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 94.49KC$ 602.88KC$ 395.62KC$ 520.59KC$ 2.47M
Total AssetsC$ 1.49MC$ 1.97MC$ 1.96MC$ 2.17MC$ 3.13M
Total DebtC$ 8.18MC$ 8.01MC$ 8.00MC$ 7.69MC$ 7.67M
Net DebtC$ 8.09MC$ 7.41MC$ 7.61MC$ 7.17MC$ 5.20M
Total LiabilitiesC$ 12.42MC$ 11.80MC$ 11.65MC$ 10.94MC$ 10.53M
Stockholders EquityC$ -10.92MC$ -9.83MC$ -9.70MC$ -8.77MC$ -7.40M
Cash Flow-
Free Cash FlowC$ -456.03K--C$ -2.05MC$ -1.12M
Operating Cash FlowC$ -456.69K-C$ -237.14KC$ -2.02MC$ -1.11M
Investing Cash FlowC$ 654.00--C$ -29.72KC$ -6.67K
Financing Cash FlowC$ -51.37K-C$ 111.72KC$ 107.58KC$ 2.16M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis